Submissions for variant NM_001710.5(CFB):c.95G>A (p.Arg32Gln) (rs641153)

Minimum review status:		Collection method:
Minimum conflict level:
		ClinVar version:

Total submissions: 11

Download table as spreadsheet

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Illumina Clinical Services Laboratory,Illumina	RCV000259759	SCV000462001	benign	Atypical hemolytic uremic syndrome	2016-06-14	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000319518	SCV000462002	benign	Macular degeneration	2016-06-14	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000319518	SCV000462005	benign	Macular degeneration	2016-06-14	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000259759	SCV000462006	benign	Atypical hemolytic uremic syndrome	2016-06-14	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000319518	SCV000484213	likely benign	Macular degeneration	2016-06-14	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000281261	SCV000484214	likely benign	Complement component 2 deficiency	2016-06-14	criteria provided, single submitter	clinical testing
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine	RCV000455762	SCV000538521	benign	not specified	2016-03-28	criteria provided, single submitter	clinical testing	Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency
Illumina Clinical Services Laboratory,Illumina	RCV001154197	SCV001315532	benign	Atypical hemolytic-uremic syndrome 4	2017-04-27	criteria provided, single submitter	clinical testing	This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.
OMIM	RCV000017453	SCV000037725	benign	Factor B fast/slow polymorphism	1994-01-01	no assertion criteria provided	literature only
OMIM	RCV000017454	SCV000037726	benign	BF*FA/S	2017-10-30	no assertion criteria provided	literature only
OMIM	RCV000017458	SCV000037730	protective	Age-related macular degeneration 14	2016-08-12	no assertion criteria provided	literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.